Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system-Reference-Cited by-同舟云学术

Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system

Published:2020-12 Issue:12 Volume:16 Page:e974-e981
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Verheye Stefan,Vrolix Mathias,Montorfano Matteo,Zivelonghi Carlo,Giannini Francesco,Bedogni Francesco,Dubois Christophe,De Bruyne Bernard,Costa Ricardo A.,Chamié Daniel,de Ribamar Costa José,Kereiakes Dean J.,Abizaid Alexandre A.,Colombo Antonio

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent;American Heart Journal;2024-11

2. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

3. Technology viewpoint: Evolution in PCI: The next major advance in implant technology to restore vessel function;Cardiovascular Revascularization Medicine;2023-11

4. First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT;eClinicalMedicine;2023-11

5. DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIOADAPTOR-RCT;Cardiovascular Revascularization Medicine;2023-10